Abstract
The study analyses, especially in an international context and in the context of the SARS-Cov-2 pandemic, the current relevance of issuing a compulsory patent right license (or patent application) — id est, national patent, European patent or via Patent Treaty Cooperation —, the transfer of technology (know-how) and access to test data, by other companies (public or private), submitted to the competent health authority and regarding vaccines and other inputs necessary to overcome or lessen the effects of this pandemic. The analysis carried out reveals that, by itself, this compulsory license is not the most appropriate legal tool to increase the availability of vaccines and other essential substances and processes to face the aforementioned pandemic at a global level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Revista de Propriedade Intelectual - Direito Constitucional e Contemporâneo
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
